The Acta Group, L.L.C.
(Acta) and The Acta Group EU, Ltd (Acta EU) are
consulting firms established to control the spiraling
costs and inefficiencies encountered by clients
seeking approvals to market chemicals, biocides,
products of biotechnology and nanotechnology,
and medical devices. Acta and Acta EU manage
products from concept to approval, utilizing the
skills and experience of professionals who have
worked in the specific product areas in government
and industry. Acta and Acta EU represent
the following disciplines:
Regulatory Affairs: Professionals skilled in the requirements for approval, including the content and form of submissions, and experienced in overall project management.
Toxicologists: Skilled in conducting literature searches, technical reviews, in-depth data reviews, study design and management, risk assessments, and exposure assessments for products regulated by the United States Environmental Protection Agency (EPA), United States Department of Agriculture (USDA), and Food and Drug Administration (FDA).
Government Affairs: Experts skilled in the workings of the regulatory agencies and adept at involving the executive and legislative branches of government, when necessary, to resolve policy issues.
Acta and Acta EU professionals have experience in regulations affecting chemical product approvals under North American (USA, Canada, and Mexico), European Union, South American, Asian, and Pacific Rim regulatory programs. They regularly track significant legislative, administrative, and scientific initiatives that relate to the business of clients marketing chemicals and medical products for multiple uses.
The Acta Group, L.L.C. ● 2200 PENNSYLVANIA AVENUE, N.W. ● SUITE 100W ● Washington, D.C. 20037 United States ● Tel: (202) 266-5020
